Fulltext

OR14-3OPIOID SUBSTITUTION TREATMENT: FROM LAW TO CLINICAL PRACTICE AND VICE VERSA

Simon, O. ; Stamm, R.

In: Alcohol and Alcoholism, 2014, vol. 49, p. i51-i51

Ajouter à la liste personnelle
    Titre
    • OR14-3OPIOID SUBSTITUTION TREATMENT: FROM LAW TO CLINICAL PRACTICE AND VICE VERSA
    Auteur
    • Simon, O.. Section d'addictologie, Service de psychiatrie communautaire, CHUV, Lausanne, Switzerland
    • Stamm, R.. Federal Office of Public Health
    Type de document
    • Postprint
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:298774
    Summary
    Background. On the edge of the <>, the Neuchatel Institute of Health Law compared regulations for opioid substitution treatment (OST) in Switzerland, France, Canada, Belgium and Tunisia. Most standards described appear to be linked to a historic repressive framework. Reference to the right to health as defined by the Committee on Economic, Social and Cultural Rights (general comment 14), appear to be absent or unclear. We present the rational for creating an interdisciplinary panel from the concerned countries, in order to prepare recommendations about how a regulative system of OST should be based on scientific evidence and right to health. Method. Following a literature review identifying barriers to best practice from an addiction medicine point of view, a DELFI technique will identify the domains requiring removal or implementation of regulations, as a priority. Results and Conclusion. Based on the report of comparative law cited above, following areas need to be considered: access to care and free choice to treatment; the articulation of different laws; conditions for authorisation; concerned substances and products; personal conditions posed to patients and professionals; requirements and limitations surrounding substitution treatment itself; the terms of ending or interruption; the protection of personal data